Amoxicillin-Induced Hypersensitivity After DRESS To Carbamazepine
Tóm tắt
The anticonvulsant hypersensitivity syndrome, also known as drug rash eosinophilia and systemic symptoms (DRESS), is a rare but severe form of adverse cutaneous reaction. Several aromatic anticonvulsant drugs, such as carbamazepine (CBZ), phenytoin, or phenobarbital have been frequently associated with the onset of DRESS. Cross-reactivity among the aromatic anticonvulsants frequently occurs (40 to 80% of patients). However, cross reactivity with other drugs such as betalactams have exceptionally been reported. We report a clinical observation describing a DRESS associated with CBZ with a subsequent hypersensitivity to amoxicillin (AMX). A 34-year-old male with a 20-year history of epilepsy was treated with valproic acid and phenobarbital. As he had frequent convulsive fits, CBZ was added. Thirty-four days later, the patient developed hyperthermia (39.5°C), cervical lymphadenopathy, and generalized cutaneous exfoliated maculae and papulae. Biochemical investigation was characterized by a white cell count of (16.1 × 103/μL, 17% eosinophils) and increased levels of aspartate aminotransferase and alanine aminotransferase (50 and 116 IU/L, respectively). CBZ was discontinued. One month later, all the symptoms were progressively relieved. Six weeks after complete recovery, prick and patch skin tests were performed. They were strongly positive at 48-hour reading. About 2 years later, the patient exhibited an extensive pruritic skin rash, 2 days after AMX intake. Laboratory exams showed eosinophilia (7%) but neither elevated liver enzymes nor renal dysfunction. All these symptoms have disappeared 5 days after AMX withdrawal. Intradermal test to AMX was positive but not to other betalactams. Throughout this clinical observation, we report a CBZ-induced DRESS and describe the possibility of cross reactivity between CBZ and AMX. This cross reactivity was observed despite the lack of chemical similarity between both drugs.
Tài liệu tham khảo
Maria CC, Kimberly AY, Nancy BE, Beth AD: Drug-induced hypersensitivity syndrome in pediatric patients. Pediatrics. 2001, 108: 485-492. 10.1542/peds.108.2.485.
Shear NH, Spielberg SP: Anticonvulsant hypersensitivity syndrome: in vitro assessment of risk. Clin Investig. 1988, 82: 1826-1832. 10.1172/JCI113798.
Silje A, Stian L, Eylert B: Cross-reactivity pattern of rash from current aromatic antiepileptic drugs. Epilepsy Res. 2008, 80: 194-200. 10.1016/j.eplepsyres.2008.04.003.
Hirsch L, Arif H, Nahm EA, Buchsbaum R, Resor SR, Bazil CW: Cross-sensitivity of skin rashes with antiepileptic drug use. Neurology. 2008, 7: 1527-1534.
Gaig P, García-Ortega P, Baltasar M, Bartra J: Drug neosensitization during anticonvulsant hypersensitivity syndrome. J Investig Allergol Clin Immunol. 2006, 16: 321-326.
Aihara Y, Ito I, Aihara M, Yokota S: Two different adverse drug reactions in a pediatric patient separated by a 15-month interval: carbamazepine-induced hypersensitivity syndrome and cefaclor-induced cutaneous eruptions. Allergologie. 2004, 27: 163-165.
Gogtay NJ, Bavdeker SB, Kshirsagar NA: Anticonvulsant hypersensitivity syndrome: a review. Expert Opin Drug Saf. 2005, 4: 571-581. 10.1517/14740338.4.3.571.
Taillia H, Alla P, Fournier B, Bounolleau P, Ouelogem M, et al: Anticonvulsant hypersensitivity syndrome and lamotrigine-associated anticonvulsant hypersensitivity syndrome. Rev Neurol. 2009, 165: 821-827. 10.1016/j.neurol.2009.02.009.
Sullivan JR, Shear NH: The drug hypersensitivity syndrome. What is the pathogenesis? Arch Dermatol. 2001, 137: 357-363.
Kano Y, Inaoka M, Shiohara T: Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia. Arch Dermatol. 2004, 140: 183-188. 10.1001/archderm.140.2.183.
Naisbitt DJ, Britschgi G: Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones. Mol Pharmacol. 2003, 63: 732-741. 10.1124/mol.63.3.732.
Aouam K, Belhadjali H, Youssef M, Chaabane A, Amri M, Boughattas AN, et al: Carbamazepine-induced DRESS and HHV6 primary infection: The importance of skin tests. Epilepsia. 2008, 49: 1630-1633. 10.1111/j.1528-1167.2008.01660.x.
Aouam K, Ben Romdhane F, Loussaïf C, Salem R, Toumi A, et al: Hypersensitivity syndrome induced by anticonvulsants: Possible cross reactivity between carbamazepine and lamotrigine. J Clinic Pharmacol. 2009, 49: 1488-1491. 10.1177/0091270009344985.
Klassen BD: Induction of hypersensitivity to a previously tolerated antiepileptic drug by a second antiepileptic drug. Epilepsia. 2001, 42: 433-435.